Skip to content
Relatix Bio

Relatix Bio

Radically different

  • Services
  • Knowledgebase
  • Partnerships
  • Our Approach
  • Contact
  • About
    • Vision
    • Our mission
    • Privacy Policy
    • FAQ
    • News
Posted on April 24, 2026 by admin
<![CDATA[Definium’s CMO says FDA talks stay aligned with their plans for advancing DT120 ODT for the treatment of depression, anxiety, and now PTSD.]]>
CategoriesImported News TagsAnxiety, Depression, Mood and emotional regulation

Post navigation

Previous PostPrevious Retrieval-Augmented Generation Versus GPT-4o for Patient-Facing Gynecological Cancer Information: Quality Evaluation
Next PostNext STAT+: Utah medical board calls for immediate suspension of state’s AI doctor experiment

This is the footer

Privacy Policy Proudly powered by WordPress